4-N-ethylamino-2,2,6,6-tetramethylpiperidine | 63738-29-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 4-N-ethylamino-2,2,6,6-tetramethylpiperidine
• 英文别名: 2,2,6,6-tetramethyl-4-ethylaminopiperidine；4-(ethylamino)-2,2,6,6,-tetramethylpiperidine；N-ethyl-2,2,6,6-tetramethylpiperidin-4-amine
• CAS: 63738-29-4
• 化学式: C₁₁H₂₄N₂
• mdl: MFCD11161665
• 分子量: 184.325
• InChiKey: IKXJYEHCFHVITH-UHFFFAOYSA-N

物化性质

• 沸点：
  218.5±8.0 °C(Predicted)
• 密度：
  0.88±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  24.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-N-ethylamino-2,2,6,6-tetramethylpiperidine 、 乙酸酐 以78%的产率得到
  参考文献：
  名称：

  REY, P.;RASSAT, A., NOUV. J. CHIM., 1983, 7, N 10, 531-533

  摘要：

  DOI：
• 作为产物：
  描述：

  4-乙酰胺基-2,2,6,6-四甲基哌啶 以96%的产率得到
  参考文献：
  名称：

  REY, P.;RASSAT, A., NOUV. J. CHIM., 1983, 7, N 10, 531-533

  摘要：

  DOI：

文献信息

• Piperidyl-triazine derivatives as stabilizers for synthetic polymers
  申请人：Chimosa Chimica Organica S.p.A.

  公开号：US04108829A1

  公开（公告）日：1978-08-22

  Novel piperidyl triazine derivatives are produced by reacting a substituted halogentriazine with a polyalcohol, a polymercaptan or a polyamine. The compounds are valuable light stabilizers for synthetic polymers, such as polyolefins, and fast to extraction in aqueous surfactant solutions.

  通过将取代的卤代三嗪与多元醇、聚巯醇或多胺反应，可以制备新型吡啶基三嗪衍生物。这些化合物是合成聚合物（如聚烯烃）的有价值的光稳定剂，并且在水性表面活性剂溶液中易于提取。
• Indenoisoquinolinone analogs and methods of use thereof
  申请人：Jagtap Prakash

  公开号：US20070049555A1

  公开（公告）日：2007-03-01

  The present invention relates to Indenoisoquinolinone Analogs, compositions comprising an effective amount of an Indenoisoquinolinone Analog and methods for treating or preventing an inflammatory disease, a reperfusion injury, diabetes mellitus, a diabetic complication, reoxygenation injury resulting from organ transplantation, an ischemic condition, a neurodegenerative disease, renal failure, a vascular disease, a cardiovascular disease, cancer, a complication of prematurity, cardiomyopathy, retinopathy, nephropathy, neuropathy, erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of an Indenoisoquinolinone Analog.

  本发明涉及Indenoisoquinolinone类似物，包括有效量的Indenoisoquinolinone类似物的组合物，以及用于治疗或预防炎症性疾病、再灌注损伤、糖尿病、糖尿病并发症、器官移植引起的再氧化损伤、缺血状况、神经退行性疾病、肾功能衰竭、血管疾病、心血管疾病、癌症、早产并发症、心肌病、视网膜病、肾病、神经病、勃起功能障碍或尿失禁的方法，包括向需要治疗的受体内给予有效量的Indenoisoquinolinone类似物。
• Compounds containing piperidine groups, as stabilizers for synthetic
  申请人：Ciba-Geigy S.p.A.

  公开号：US04618634A1

  公开（公告）日：1986-10-21

  Novel compounds containing piperidine groups, of the general formula ##STR1## in which R.sub.1 is hydrogen, O--, cyanomethyl, C.sub.1 -C.sub.12 -alkyl, C.sub.3 -C.sub.12 -alkenyl or -alkynyl, C.sub.7 -C.sub.12 -aralkyl or C.sub.1 -C.sub.12 -acyl, m is an integer from 1 to 12, n is an integer from 1 to 3 and A is an amine radical, are suitable as light stabilizers, heat stabilizers and oxidation stabilizers for synthetic polymers. Processes for their preparation are also described.

  含有哌啶基团的新型化合物，其通式为##STR1## 其中R.sub.1为氢，O-，氰甲基，C.sub.1-C.sub.12-烷基，C.sub.3-C.sub.12-烯基或-炔基，C.sub.7-C.sub.12-芳基烷基或C.sub.1-C.sub.12-酰基，m为1至12的整数，n为1至3的整数，A为胺基基团，适用于合成聚合物的光稳定剂、热稳定剂和氧化稳定剂。还描述了它们的制备过程。
• Indenoisoquinolinone Analogs and Methods of Use Thereof
  申请人：JAGTAP Prakash

  公开号：US20100004220A1

  公开（公告）日：2010-01-07

  The present invention relates to Indenoisoquinolinone Analogs, compositions comprising an effective amount of an Indenoisoquinolinone Analog and methods for treating or preventing an inflammatory disease, a reperfusion injury, diabetes mellitus, a diabetic complication, reoxygenation injury resulting from organ transplantation, an ischemic condition, a neurodegenerative disease, renal failure, a vascular disease, a cardiovascular disease, cancer, a complication of prematurity, cardiomyopathy, retinopathy, nephropathy, neuropathy, erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of an Indenoisoquinolinone Analog.

  本发明涉及Indenoisoquinolinone类似物，包括有效量的Indenoisoquinolinone类似物组成的组合物，以及用于治疗或预防炎症性疾病、再灌注损伤、糖尿病、糖尿病并发症、器官移植引起的再氧化损伤、缺血状况、神经退行性疾病、肾功能衰竭、血管疾病、心血管疾病、癌症、早产并发症、心肌病、视网膜病变、肾病、神经病变、勃起功能障碍或尿失禁的方法，包括向需要的受体中注射有效量的Indenoisoquinolinone类似物。
• Nitrogen-containing heterocyclic compound
  申请人：Murakata Chikara

  公开号：US20090054407A1

  公开（公告）日：2009-02-26

  The present invention provides a nitrogen-containing heterocyclic compound represented by formula (I): wherein W represents a nitrogen atom or —CH—; X represents —C(═O)— or —CHR 4 — (wherein R 4 represents a hydrogen atom, or the like); R 1 represents a group represented by the following formula: [wherein Q 1 represents a nitrogen atom or —CR 8 — (wherein R 8 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like). Q 2 represents —NR 15 — (wherein R 15 represents a hydrogen atom, or the like) and R 5 and R 6 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like]; and R 2 and R 3 may be the same or different and each represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, or the like} or a pharmaceutically acceptable salt thereof, and the like.

  本发明提供了一种含氮杂环化合物，其由式(I)表示：其中W代表氮原子或—CH—；X代表—C(═O)—或—CHR4—（其中R4代表氢原子或类似物）；R1代表由以下式表示的基团：[其中Q1代表氮原子或—CR8—（其中R8代表氢原子、取代或未取代的低级烷基或类似物）。Q2代表—NR15—（其中R15代表氢原子或类似物），R5和R6可以相同也可以不同，每个代表氢原子、取代或未取代的低级烷基或类似物]；R2和R3可以相同也可以不同，每个代表氢原子、卤素、取代或未取代的低级烷基或类似物}或其药学上可接受的盐等。